Kangmei Pharma | 600518 - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.38M 172K 2026-03
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Genomma Lab Internacional MXN 975.25M 1.48M 2026-03
Hypermarcas BRL 639.46M 6.52M 2025-12
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Jiangsu Hengrui CNY 6.64B 0 2026-03
Kangmei Pharma CNY 13.83B 0 2026-03
Moderna USD 391M 2M 2025-09
Organon & Co USD 260.32M 333K 2025-12
Revvity USD 111.8M 1.57M 2026-03
Sh Fosun Pharma CNY 2.67B 0 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Viatris USD 1.16B 5.27M 2026-03
Wuxi Apptec CNY 2.98B 123.4M 2025-12
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2026-03